Suppr超能文献

新型喹诺酮类抗菌药物 DC-159a 和 DX-619 在幼年大鼠中的软骨毒性和毒代动力学。

Chondrotoxicity and toxicokinetics of novel quinolone antibacterial agents DC-159a and DX-619 in juvenile rats.

机构信息

Medicinal Safety Research Laboratories, Daiichi Sankyo Co. LTD., Edogawa-ku, Tokyo, Japan.

出版信息

Toxicology. 2010 Oct 9;276(2):122-7. doi: 10.1016/j.tox.2010.07.017. Epub 2010 Aug 3.

Abstract

Quinolone antibacterial agents are extensively utilized in antimicrobial chemotherapy. However, they have been reported to induce arthropathy in juvenile animals, and the mechanism has not been clarified. Recently, we have demonstrated that Dusp1, Tnfrsf12a, Ptgs2, Fos, Mt1a, Plaur, Mmp3, Sstr1 and Has2 genes change in the articular cartilage of juvenile rats with a single oral administration of ofloxacin (OFLX), suggesting that these genes are involved in the induction of OFLX-induced chondrotoxicity. In the present study, to compare the chondrotoxic potential between new synthesized quinolones DC-159a and DX-619, and OFLX, they were orally administered by gavage at a dose level of 300 or 900 mg/kg/day to male juvenile Sprague-Dawley (SD) rats, 3 weeks of age, for 7 days. Then the distal humerus and femur were subjected to microscopic examination. Moreover, concentrations of these quinolones in the femoral articular cartilage were measured in male juvenile SD rats following a single oral administration at 100, 300 or 900 mg/kg. Furthermore, gene expression of Dusp1, Tnfrsf12a, Ptgs2, Fos, Mt1a, Plaur, Mmp3, Sstr1 and Has2 was investigated in the articular cartilage of the distal femur in male juvenile SD rats treated with 900 mg/kg of DC-159a or DX-619 by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) analysis. In a microscopic examination, no changes in the articular cartilage were observed in any animal administered DC-159a or DX-619. On the contrary, cavity formation and chondrocyte cluster in the cartilage of distal humerus and femur were noted in animals receiving OFLX at 300 mg/kg/day or more. In toxicokinetic analysis, the maximum concentration (C(max)) value in the articular cartilage (cartilage C(max)) of DC-159a or DX-619 at 900 mg/kg was lower than that of OFLX at 300 mg/kg. However, the area under the cartilage concentration-time curve (cartilage AUC)(0-24h) value of DC-159a or DX-619 at 900 mg/kg was higher than that of OFLX at 300 mg/kg. In qRT-PCR analysis, up-regulated Dusp1, Fos and Mt1a, and down-regulated Sstr1 and Has2 genes were seen in the femoral articular cartilage of rats given DX-619 or DC-159a at 900 mg/kg. However, Tnfrsf12a, Ptgs2, Plaur and Mmp3 genes, which were up-regulated in the distal femoral articular cartilage exposed to OFLX, did not increase or slightly increased. In conclusion, the penetration of DC-159a or DX-619 into the cartilage was low compared with that of OFLX, and no obvious changes in Tnfrsf12a, Ptgs2, Plaur and Mmp3 genes were observed in the articular cartilage of juvenile rats treated with DC-159a or DX-619, which was likely to be responsible for non-chondrotoxic potentials of DC-159a and DX-619.

摘要

喹诺酮类抗菌药物在抗菌化学疗法中被广泛应用。然而,它们已被报道会在幼年动物中引起关节病,但其机制尚未阐明。最近,我们已经证明,在幼年大鼠单次口服氧氟沙星(OFLX)后,软骨中的 Dusp1、Tnfrsf12a、Ptgs2、Fos、Mt1a、Plaur、Mmp3、Sstr1 和 Has2 基因发生变化,表明这些基因参与了 OFLX 诱导的软骨毒性的诱导。在本研究中,为了比较新合成的喹诺酮 DC-159a 和 DX-619 与 OFLX 的软骨毒性潜力,将它们以 300 或 900mg/kg/天的剂量水平通过灌胃给药至 3 周龄雄性幼年 Sprague-Dawley(SD)大鼠,持续 7 天。然后对远端肱骨和股骨进行显微镜检查。此外,在雄性幼年 SD 大鼠中,在单次口服 100、300 或 900mg/kg 后,测量了这些喹诺酮在股骨关节软骨中的浓度。此外,通过定量实时逆转录-聚合酶链反应(qRT-PCR)分析,研究了在接受 900mg/kg DC-159a 或 DX-619 治疗的雄性幼年 SD 大鼠的远端股骨关节软骨中 Dusp1、Tnfrsf12a、Ptgs2、Fos、Mt1a、Plaur、Mmp3、Sstr1 和 Has2 的基因表达。在显微镜检查中,给予 DC-159a 或 DX-619 的任何动物的关节软骨均未发生变化。相反,在接受 OFLX 300mg/kg/天或更高剂量治疗的动物中,远端肱骨和股骨的软骨中出现了腔形成和软骨细胞簇。在毒代动力学分析中,900mg/kg 时 DC-159a 或 DX-619 的最大浓度(C(max))值(软骨 C(max))低于 300mg/kg 时的 OFLX。然而,900mg/kg 时 DC-159a 或 DX-619 的软骨浓度-时间曲线下面积(软骨 AUC)(0-24h)值高于 300mg/kg 时的 OFLX。在 qRT-PCR 分析中,在接受 900mg/kg 的 DX-619 或 DC-159a 的大鼠的股骨关节软骨中,上调了 Dusp1、Fos 和 Mt1a,下调了 Sstr1 和 Has2 基因。然而,在暴露于 OFLX 的远端股骨关节软骨中上调的 Tnfrsf12a、Ptgs2、Plaur 和 Mmp3 基因没有增加或略有增加。总之,与 OFLX 相比,DC-159a 或 DX-619 进入软骨的能力较低,并且在接受 DC-159a 或 DX-619 治疗的幼年大鼠的关节软骨中未观察到 Tnfrsf12a、Ptgs2、Plaur 和 Mmp3 基因的明显变化,这可能是 DC-159a 和 DX-619 非软骨毒性潜力的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验